Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02332187
Other study ID # Protocol 12-0807-F6A
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date January 3, 2013
Est. completion date May 5, 2017

Study information

Verified date February 2022
Source University of Kentucky
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients that are on mechanical ventilators in medical intensive care units (MICU) have extremely weak leg muscles. Currently there is no treatment to prevent or reverse this weakness. Treatments with a thigh muscle stimulator, called an All Stim 2, can improve leg muscle strength and help patients regain leg function after knee surgery. The purpose of the present study is to determine if treatments with the All Stim 2 device can also improve leg muscle strength in patients on mechanical ventilation.


Description:

The objective for this study is to determine if daily exercise using All-Stim 2 stimulation of quadriceps muscles will increase leg strength and improve outcomes (duration of hospitalization, long term mobility, long term disability) for mechanically ventilated MICU patients. The investigators plan to randomize patients accepted into this protocol to administration of either sham exercise (i.e. placement of All-Stim 2 units on the legs for 30 minutes a day without activation of the electrical stimulation program) or active exercise (placement of All-Stim 2 electrodes on both legs and stimulating quadriceps muscles to rhythmically contract for 30 minutes a day). The two groups (sham and active exercise) will be treated for 30 minutes a day for seven days. The effects of exercise on quadriceps strength will be assessed by measuring quadriceps force generation (QuadTw) in response to magnetic stimulation of the femoral nerves. The QuadTw assessment will be made immediately before institution of sham or active exercise and will repeated one day after the conclusion of the seven day training regimen. Chart review and patient follow-up will be used to determine if this treatment regimen also has an impact on clinical outcome measures, i.e. duration of hospitalization.


Recruitment information / eligibility

Status Terminated
Enrollment 15
Est. completion date May 5, 2017
Est. primary completion date May 5, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients requiring mechanical ventilation for more than 48 hours - Respiratory failure present Exclusion Criteria: - The physician caring for the patient determines that the patient is too unstable - Use of high dose pressors (more than 15 mcg/min of norepinephrine or more than 15 mg/kg/min of dopamine) - Use of more than 80% FiO2 (fractional concentration of oxygen) or more than 15 cm H2O (water) of PEEP (positive end expiratory pressure) - Presence of a cardiac pacemaker or implanted defibrillator - Use of neuromuscular blocking agents within the 48 hours preceding testing - History of a preexisting neuromuscular disease - Presence of profound and uncorrectable hypokalemia (less than 2.5) or hypophosphatemia (less than 1.0) - Pregnancy - If the patient is a prisoner - If the patient is institutionalized - If it is thought that the patient will have care withdrawn within 7 days

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Active electrical stimulation using an All Stim stimulator
This is an FDA approved stimulator that is used for strengthening the quadriceps muscle.
Sham electrical stimulation using an All Stim stimulator
With this intervention the All Stim unit is turned off and no electrical stimulation is provided.

Locations

Country Name City State
United States Chandler Hospital Lexington Kentucky

Sponsors (1)

Lead Sponsor Collaborator
Gerald Supinski

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Quadriceps Muscle Strength The investigators will measure quadriceps leg strength before and after one week of either sham or active electrical stimulation of the quadriceps muscle. Baseline and One week
Secondary Duration of Hospitilization The investigators will record the total time patients remain hospitilized after entry into the study. Baseline to discharge in weeks, up to five weeks
See also
  Status Clinical Trial Phase
Completed NCT00997269 - Benefit of CoQ-10 in Patients on Statins N/A
Completed NCT00473161 - Use of Surface Electromyography Biofeedback to Improve Reaching in Children With Cerebral Palsy Phase 1/Phase 2
Recruiting NCT02478411 - Early Cycloergometric Physiotherapy in Critically Ill Patients With Invasive Mechanical Ventilation N/A
Terminated NCT01895647 - Effect of Different Electric Muscle Stimulation in Patients With Severe Sepsis and Respiratory Failure N/A
Completed NCT02757131 - Dedicated Ambulator-assisted Physical Activity to Improve Hospital Outcome Measures in Elderly Patients N/A
Recruiting NCT01911312 - Evaluation of Thermal-Aided Muscle Stimulation N/A
Completed NCT02010398 - Effects of the Cross-Training in Patients With Multiple Sclerosis N/A
Completed NCT01154517 - Utility of the History and Physical Exam in the Emergency Department N/A
Completed NCT04393909 - Improving Safety of Diagnosis and Therapy in the Inpatient Setting N/A
Terminated NCT02247895 - Treatment of Muscle Weakness in Critically Ill Patients N/A
Active, not recruiting NCT01032993 - Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms Phase 2/Phase 3
Withdrawn NCT00583206 - Muscle Atrophy in Sepsis N/A
Completed NCT01881477 - Effect of Therapeutic Modalities on the Physical Fitness and Functional Capacity in Critical Patient N/A
Completed NCT00797407 - Effectiveness of Creatine in Preventing Muscle Aching From Cholesterol-Lowering Statin Drugs N/A
Recruiting NCT00666744 - A Randomised Controlled Trial of Family Mediated Exercises (FAME) Following Stroke Phase 3